Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels
Status:
COMPLETED
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The sample was randomly divided into 3 groups consisting of patients who received Magnesium Sulfate 30 mg/Kg, Lidocaine 1.5 mg/Kg, and Control. These groups will be checked for hemodynamic changes and cortisol values.